Springfield, MO

Log in Subscribe

Novartis makes offer to buy German cancer drugmaker

Posted online

Swiss health care company Novartis has made a tender offer to acquire German cancer drugmaker MorphoSys.

Novartis is offering $73 per share, a premium of around 142%.

Novartis also recently announced it's pausing enrollment of new patients in clinical trials for Kisqali, a breast cancer treatment.

Read more from Quartz.


No comments on this story |
Please log in to add your comment
Editors' Pick
Open for Business: The Flying Lap

Plaza Shopping Center gained an arcade with the March 1 opening of The Flying Lap LLC; the repurposing of space operated by Burrell Behavioral Health resulted in the March 18 opening of the company’s second autism center; and a group of downtown business owners teamed up to reopen J.O.B. Public House.

Most Read
Update cookies preferences